The Impact of Over Three Years Commercial Use of Ex Vivo Normothermic Machine Perfusion for Liver Transplantation in the <scp>USA</scp>: A <scp>UNOS</scp>/<scp>OPTN</scp> Database Analysis
In conclusion, commercial use of NMP has expanded the donor pool by accelerated usage of marginal livers such as DCD and older donors by permitting longer preservation and functional assessment of the liver. In addition, the usage of NMP for DCD LTs was associate with a reduced incidence of rejection, PNF, graft failure due to IC and HAT.
Authors
- James F. Markmann (ORCID: https://orcid.org/0000-0002-2762-6535)
- Naoru Koizumi (ORCID: https://orcid.org/0000-0001-8722-0898)
- Takayuki Yamamoto (ORCID: https://orcid.org/0000-0001-8216-0750)
Institutions
- George Mason University (US)
- Albany Medical Center Hospital (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Artificial Organs
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1111/aor.14975
- Citations
- 3
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 6.02